1000340-06-6 Usage
General Description
Methyl 5-(4-bromophenylamino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylate is a chemical compound with a complex structure consisting of a benzoimidazole ring with fluorine, methyl, and carboxylate functional groups. It also contains a bromophenylamino substituent. methyl 5-(4-bromophenylamino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylate has potential applications in medicinal chemistry due to its structural features, which may allow it to interact with biological targets in the body. It could be used in the development of pharmaceutical drugs, particularly those targeting specific enzymes or receptors. Additionally, it may have properties of interest in the field of organic synthesis and material science. However, further research and testing are necessary to fully understand the potential uses and properties of this chemical.
Check Digit Verification of cas no
The CAS Registry Mumber 1000340-06-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,0,3,4 and 0 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1000340-06:
(9*1)+(8*0)+(7*0)+(6*0)+(5*3)+(4*4)+(3*0)+(2*0)+(1*6)=46
46 % 10 = 6
So 1000340-06-6 is a valid CAS Registry Number.
1000340-06-6Relevant articles and documents
INTERMEDIATES OF MITOGEN-ACTIVATED PROTEIN KINASE KINASE (MAP2K OR MEK) INHIBITORS AND PROCESS FOR THEIR PREPARATION
-
, (2018/04/21)
The present invention relates to intermediates of Mitogen-activated protein kinase kinase (MAP2K or MEK) inhibitors such as Selumetinib, Binimetinib and process for their preparation. The present invention also relates to process for the 5 preparation of MEK inhibitors such as Selumetinib, and Binimetinib.
